267 related articles for article (PubMed ID: 30178774)
1. Focal therapy for localized prostate cancer: is there a "middle ground" between active surveillance and definitive treatment?
Demirel CH; Altok M; Davis JW
Asian J Androl; 2018 Aug; 21(1):37-44. PubMed ID: 30178774
[TBL] [Abstract][Full Text] [Related]
2. Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance Imaging Have a Role?
Stonier T; Tin AL; Sjoberg DD; Jibara G; Vickers AJ; Fine S; Eastham J
J Urol; 2021 Apr; 205(4):1063-1068. PubMed ID: 33216696
[TBL] [Abstract][Full Text] [Related]
3. Imaging Characteristics of Prostate Cancer Patients Who Discontinued Active Surveillance on 3-T Multiparametric Prostate MRI.
Habibian DJ; Liu CC; Dao A; Kosinski KE; Katz AE
AJR Am J Roentgenol; 2017 Mar; 208(3):564-569. PubMed ID: 28075651
[TBL] [Abstract][Full Text] [Related]
4. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
5. Surveillance after prostate focal therapy.
Tay KJ; Amin MB; Ghai S; Jimenez RE; Kench JG; Klotz L; Montironi R; Muto S; Rastinehad AR; Turkbey B; Villers A; Polascik TJ
World J Urol; 2019 Mar; 37(3):397-407. PubMed ID: 29948045
[TBL] [Abstract][Full Text] [Related]
6. Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Large Multicenter Cohort Study.
von Hardenberg J; Borkowetz A; Siegel F; Kornienko K; Westhoff N; Jordan TB; Hoffmann M; Drerup M; Lieb V; Taymoorian K; Schostak M; Ganzer R; Höfner T; Cash H; Bruendl J;
Eur Urol Focus; 2021 Sep; 7(5):1002-1010. PubMed ID: 33877047
[TBL] [Abstract][Full Text] [Related]
7. Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.
Ahmed HU; Akin O; Coleman JA; Crane S; Emberton M; Goldenberg L; Hricak H; Kattan MW; Kurhanewicz J; Moore CM; Parker C; Polascik TJ; Scardino P; van As N; Villers A;
BJU Int; 2012 Jun; 109(11):1636-47. PubMed ID: 22077593
[TBL] [Abstract][Full Text] [Related]
8. Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project.
Muller BG; van den Bos W; Brausi M; Fütterer JJ; Ghai S; Pinto PA; Popeneciu IV; de Reijke TM; Robertson C; de la Rosette JJ; Scionti S; Turkbey B; Wijkstra H; Ukimura O; Polascik TJ
World J Urol; 2015 Oct; 33(10):1503-9. PubMed ID: 25559111
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy.
Fasulo V; Cowan JE; Maggi M; Washington SL; Nguyen HG; Shinohara K; Lazzeri M; Casale P; Carroll PR
Eur Urol Oncol; 2022 Feb; 5(1):61-69. PubMed ID: 33069628
[TBL] [Abstract][Full Text] [Related]
10. Low-risk prostate cancer patients without visible tumor (T1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol.
Lee DH; Koo KC; Lee SH; Rha KH; Choi YD; Hong SJ; Chung BH
Jpn J Clin Oncol; 2013 May; 43(5):553-8. PubMed ID: 23580758
[TBL] [Abstract][Full Text] [Related]
11. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
[TBL] [Abstract][Full Text] [Related]
12. Focal therapy of localized prostate cancer.
Fujihara A; Ukimura O
Int J Urol; 2022 Nov; 29(11):1254-1263. PubMed ID: 35996758
[TBL] [Abstract][Full Text] [Related]
13. Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer.
Orczyk C; Barratt D; Brew-Graves C; Peng Hu Y; Freeman A; McCartan N; Potyka I; Ramachandran N; Rodell R; Williams NR; Emberton M; Ahmed HU
J Urol; 2021 Apr; 205(4):1090-1099. PubMed ID: 33315505
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer.
Chu CE; Cowan JE; Lonergan PE; Washington SL; Fasulo V; de la Calle CM; Shinohara K; Westphalen AC; Carroll PR
Eur Urol Oncol; 2022 Oct; 5(5):537-543. PubMed ID: 33483265
[TBL] [Abstract][Full Text] [Related]
15. Moving Forward the State of the Art in Prostate Cancer Treatment: Targeted Focal Therapy.
Crawford ED; Rove KO; Stone NN; Lucia MS; Barqawi AB; La Rosa FG
Urol Pract; 2014 Sep; 1(3):156-164. PubMed ID: 37537812
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI.
Connor MJ; Gorin MA; Ahmed HU; Nigam R
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):232-243. PubMed ID: 32051551
[TBL] [Abstract][Full Text] [Related]
18. Current trends and new frontiers in focal therapy for localized prostate cancer.
Mendez MH; Joh DY; Gupta R; Polascik TJ
Curr Urol Rep; 2015 Jun; 16(6):35. PubMed ID: 25903803
[TBL] [Abstract][Full Text] [Related]
19. The role of focal therapy in the management of localised prostate cancer: a systematic review.
Valerio M; Ahmed HU; Emberton M; Lawrentschuk N; Lazzeri M; Montironi R; Nguyen PL; Trachtenberg J; Polascik TJ
Eur Urol; 2014 Oct; 66(4):732-51. PubMed ID: 23769825
[TBL] [Abstract][Full Text] [Related]
20. Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials.
Wang AZ; Lebastchi AH; O'Connor LP; Ahdoot M; Mehralivand S; Yerram N; Taneja SS; George AK; Sanchez-Salas R; Ward JF; Laguna P; de la Rosette J; Pinto PA
World J Urol; 2021 Mar; 39(3):729-739. PubMed ID: 33388878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
